Search Results - "TRELEAVEN, D"

Comparison of the clinical effectiveness and safety between the use of denosumab vs bisphosphonates in renal transplant patients by McKee, H., Ioannidis, G., Lau, A., Treleaven, D., Gangji, A., Ribic, C., Wong-Pack, M., Papaioannou, A., Adachi, J. D.

“…Summary A retrospective chart review was conducted on 85 renal transplant patients aged 19–88 years, treated with denosumab or bisphosphonate therapy. Bone…”
Get full text

The Long‐Term Quality of Life of Living Kidney Donors: A Multicenter Cohort Study by Clemens, K., Boudville, N., Dew, M. A., Geddes, C., Gill, J. S., Jassal, V., Klarenbach, S., Knoll, G., Muirhead, N., Prasad, G. V. R., Storsley, L., Treleaven, D., Garg, A.

“…Previous studies that described the long‐term quality of life of living kidney donors were conducted in single centers, and lacked data on a healthy nondonor…”
Get full text

Economic Consequences Incurred by Living Kidney Donors: A Canadian Multi‐Center Prospective Study by Klarenbach, S., Gill, J. S., Knoll, G., Caulfield, T., Boudville, N., Prasad, G. V. R., Karpinski, M., Storsley, L., Treleaven, D., Arnold, J., Cuerden, M., Jacobs, P., Garg, A. X.

“…Some living kidney donors incur economic consequences as a result of donation; however, these costs are poorly quantified. We developed a framework to…”
Get full text

Correction to: Comparison of the clinical effectiveness and safety between the use of denosumab vs bisphosphonates in renal transplant patients by McKee, H., Ioannidis, G., Lau, A., Treleaven, D., Gangji, A., Ribic, C., Wong-Pack, M., Papaioannou, A., Adachi, J.D.

“…The original version of this article, published on 03 January 2020 contained a mistake. An author’s name was misspelled…”
Get full text

Disparities in Deceased Donor Kidney Offer Acceptance: A Survey of Canadian Transplant Nephrologists, General Surgeons and Urologists by Vinson, A. J., Cardinal, H., Parsons, C., Tennankore, K. K., Mainra, R., Maru, K., Treleaven, D., Gill, J.

“…Background: Significant variability in organ acceptance thresholds have been demonstrated across the United States, but data regarding the rate and rationale…”
Get full text

Health Outcomes for Living Kidney Donors with Isolated Medical Abnormalities: A Systematic Review by Young, A., Storsley, L., Garg, A. X., Treleaven, D., Nguan, C. Y., Cuerden, M. S., Karpinski, M.

“…Individuals with isolated medical abnormalities (IMAs) are undergoing living donor nephrectomy more frequently. Knowledge of health risks for these living…”
Get full text

Accepting Kidneys from Older Living Donors: Impact on Transplant Recipient Outcomes by Young, A., Kim, S. J., Speechley, M. R., Huang, A., Knoll, G. A., Prasad, G. V. Ramesh, Treleaven, D., Diamant, M., Garg, A. X.

“…Older living kidney donors are regularly accepted. Better knowledge of recipient outcomes is needed to inform this practice. This retrospective cohort study…”
Get full text

Differences in tolerance for health risk to the living donor among potential donors, recipients, and transplant professionals by Young, A., Karpinski, M., Treleaven, D., Waterman, A., Parikh, C.R., Thiessen-Philbrook, H., Yang, R.C., Garg, A.X.

“…In organ donation, the donor, recipient, and transplant team must all accept potential health risks to the donor and any uncertainties. To gauge these risks,…”
Get full text

Utility of ultrasonographic venous assessment prior to forearm arteriovenous fistula creation by Brimble, K S, Rabbat, Ch G, Treleaven, D J, Ingram, A J

“…The purpose of this study was to evaluate the clinical utility of Doppler ultrasound (US) prior to native forearm arteriovenous fistula (AVF) creation. US…”
Get more information

Management of asymptomatic cholelithiasis for patients awaiting renal transplantation by JACKSON, T, TRELEAVEN, D, ARLEN, D, D'SA, A, LAMBERT, K, BIRCH, D. W

“…There is no consensus regarding the most appropriate management of asymptomatic cholelithiasis in patients awaiting renal transplantation. Cholecystectomy is…”
Get full text

Event adjudication and data monitoring in an intensive care unit observational study of thromboprophylaxis by Cook, D, Sinuff, T, Zytaruk, N, Rabbat, C, Lee, A, O'Donnell, M, Thabane, L, Linkins, L, Treleaven, D, Patel, R, Meade, M, Crowther, M, Marshall, J.C, Douketis, J

“…Abstract Background The objective of this report is to describe the roles, responsibilities and recommendations of a 3-member Event Adjudication Committee…”
Get full text

Randomized study of temporary hemodialysis catheters by Oliver, M J, Edwards, L J, Treleaven, D J, Lambert, K, Margetts, P J

“…Temporary catheters are still essential for acute dialysis access but their performance has not been compared in randomized trials. We conducted a randomized…”
Get full text

Infrared Spectroscopy of Human Apolipoprotein Fragments in SDS/D2O:  Relative Lipid-Binding Affinities and a Novel Amide I Assignment by Shaw, R. A, Buchko, G. W, Wang, G, Rozek, A, Treleaven, W. D, Mantsch, H. H, Cushley, R. J

“…Infrared absorption spectra are reported for six apolipoprotein fragments in SDS/D2O. Five of the peptides correspond to proposed lipid-binding domains of…”
Get full text

Acute dialysis risk in living kidney donors by LAM, Ngan, ANJIE HUANG, PARIKH, Chirag R, RAMESH PRASAD, G. V, TRELEAVEN, Darin J, YOUNG, Ann, GARG, Amit X, FELDMAN, Liane S, GILL, John S, KARPINSKI, Martin, KIM, Joseph, KLARENBACH, Scott W, KNOLL, Greg A, LENTINE, Krista L, NGUAN, Chris Y

“…Reduced kidney function confers a higher risk of acute kidney injury at the time of an inciting event, such as sepsis. Whether the same is true in those with…”
Get full text

The Canadian ACE-inhibitor trial to improve renal outcomes and patient survival in kidney transplantation—study design by Knoll, Greg A., Cantarovitch, Marcelo, Cole, Ed, Gill, John, Gourishankar, Sita, Holland, Dave, Kiberd, Bryce, Muirhead, Norman, Prasad, Ramesh, Tibbles, Lee Anne, Treleaven, Darin, Fergusson, Dean

“…Background. In non-transplant patients with chronic kidney disease and proteinuria, inhibition of the renin–angiotensin system with an ACE-inhibitor or an…”
Get full text

Interobserver and intraobserver variability using the Fuhrman grading system for renal cell carcinoma by Al-Aynati, Maamoun, Chen, Vicky, Salama, Samih, Shuhaibar, Hafez, Treleaven, Darin, Vincic, Lydia

“…Histologic grading of renal cell carcinoma has been shown to be second to staging in prognostic significance. A 4-tier grading scheme proposed by Fuhrman et al…”
Get full text

Differences in tolerance for health risk to the living donor among potential donors, recipients, and transplant professionals. Commentary by MAIORANO, A, SCHENA, F. P, YOUNG, A, KARPINSKI, M, TRELEAVEN, D, WATERMAN, A, PARIKH, C. R, THIESSEN-PHILBROOK, H, YANG, R. C, GARG, A. X

Get full text

Surface diffusion in human serum lipoproteins by Cushley, R J, Treleaven, W D, Parmar, Y I, Chana, R S, Fenske, D B

“…From the viscosity dependence of the 31P NMR signals, the diffusion coefficients DT of phospholipid molecules in the surface monolayer of HDL, LDL and VLDL…”
Get more information

Lipid-lipid interactions in reconstituted high-density lipoproteins by deuterium nuclear magnetic resonance by Fenske, David B., Parmar, Yashpal I., Treleaven, W. Dale, Chana, Ravinder S., Cushley, Robert J.

“…Lipid-lipid interactions between the core and monolayer have been studied by using reconstituted high-density lipoproteins (rHDLs) composed of apoHDL3 with…”
Get full text

Use of erythropoietins in patients with renal transplants by Treleaven, Darin J, Clase, Catherine M

“…Normalisation of haemoglobin is hazardous, ineffective, and costly…”
Get full text